|
CFL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
5.83010306698384E-11 |
| Normal-vs-Stage3 |
1.200510E-03 |
| Normal-vs-Stage4 |
2.618600E-03 |
| Stage1-vs-Stage2 |
6.491200E-01 |
| Stage1-vs-Stage3 |
7.481200E-03 |
| Stage1-vs-Stage4 |
2.995400E-01 |
| Stage2-vs-Stage3 |
5.011700E-02 |
| Stage2-vs-Stage4 |
3.405400E-01 |
| Stage3-vs-Stage4 |
5.184000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.20260001746209E-09 |
| Normal-vs-Asian |
1.606410E-01 |
| Caucasian-vs-AfricanAmerican |
2.746000E-01 |
| Caucasian-vs-Asian |
1.830420E-01 |
| AfricanAmerican-vs-Asian |
5.112800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
7.6260000536621E-09 |
| Male-vs-Female |
1.331730E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.821800E-04 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.9853008126347E-12 |
| Normal-vs-Extreme_Obese |
3.47819999468868E-08 |
| Normal_Weight-vs-Extreme_Weight |
1.131800E-01 |
| Normal_Weight-vs-Obese |
4.109000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.041600E-01 |
| Extreme_Weight-vs-Obese |
1.730960E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.624000E-01 |
| Obese-vs-Extreme_Obese |
6.872200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.736100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62880819942757E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
9.29190000498181E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.921200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.668000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.321800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.336200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.834800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.117000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
3.61669999999759E-05 |
| Normal-VS-KIRP CIMP |
3.665600E-02 |
| Normal-VS-Unclassified PRCC |
2.81840106808318E-11 |
| Type1 PRCC-VS-Type2 PRCC |
2.576200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.109400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.332200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.756200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.033800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.390000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.56689994312842E-10 |
| Normal-vs-N1 |
3.193900E-02 |
| Normal-vs-N2 |
8.03999999909877E-08 |
| N0-vs-N1 |
3.919800E-02 |
| N0-vs-N2 |
9.242900E-03 |
| N1-vs-N2 |
7.010300E-04 |
|
|
